The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 20.50
Bid: 20.00
Ask: 21.00
Change: -0.25 (-1.20%)
Spread: 1.00 (5.00%)
Open: 20.75
High: 20.75
Low: 20.50
Prev. Close: 20.75
IOF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Finalised Terms for IO9 & Q3 Production Update

28 Oct 2022 07:00

RNS Number : 4131E
Iofina PLC
28 October 2022
 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014

28 October 2022

 

Iofina plc

("Iofina", the "Company" or the "Group")

(LSE AIM: IOF)

 

Finalised terms for IO#9

Q3 Production Update

 

Iofina plc, specialists in the exploration and production of iodine and manufacturers of specialty chemical products, is pleased to announce that it has now executed all agreements with a new brine supply partner to construct its latest IOsorb® iodine plant, IO#9, in Western Oklahoma.

 

This region of Western Oklahoma is an area of significant oil and gas development with a consequent growing brine supply. The Board believes that the site provides an excellent location for Iofina's newest plant, which will employ IOsorb® technology to isolate iodine from the iodine-rich brine stream which is co-produced during our partner's oil and gas production. Iofina anticipates expanding iodine production in this region to create a new core area for the Company and is actively developing plans for a second plant in this area.

 

To minimise supply chain impacts and expedite IO#9's construction, the Company pre-ordered major items and secured contractors in advance. The Company will also relocate the equipment from IO#5 as part of its building plans. The Company remains mindful of the impact of supply chain issues, but currently anticipates a construction time of six months, after which Iofina will be operating six iodine production plants in Oklahoma. Once in operation, IO#9 will immediately contribute to cash flow. Full payback of its costs expected in less than two years with production of crystalline iodine targeted between 100 to 150 metric tonnes ("MT") per annum. Additionally, as previously announced in July this year, Iofina obtained a term loan from its banking partner to support this project. 

 

In the third quarter of this year ("Q3"), at the Company's five IOsorb® production facilities in Oklahoma, Iofina Resources produced 143.0 MT of crystalline iodine. This production is in line with the Company's expectations and Iofina is on track to produce 255-275 MT of crystalline iodine in the second half of this year.

 

Commenting, President and CEO Dr. Tom Becker, stated: "We are delighted to have agreed on the terms to construct our newest iodine plant, IO#9, in Western Oklahoma, enabling us to move forward with our next growth phase. With our current IOsorb® facilities operating at expected rates, the addition of IO#9 will deliver a major step change in our overall iodine production.

 

"IO#9's construction will be underway shortly, whilst the relocating of the decommissioned IO#5 plant will help to both accelerate the project and keep costs down. The current timeline will see IO#9 online in approximately six months. We look forward to updating the market on the progress of construction in due course."

 

Enquiries:

 

Dr. Tom Becker

CEO & President

Iofina plc

Tel: +44 (0)20 3006 3135

 

Christopher Raggett

Tim Redfern/Barney Hayward (ECM)

finnCap Ltd

Tel: +44 (0)20 7220 0500

 

Kingsley Wilson

Chrystal Capital Partners LLP

Tel: +44 (0)20 7850 4761

 

Media Contact:

Charles Goodwin/Laurie Gellhorn

Yellow Jersey PR Limited

Tel: +44 (0)7747 788 221

About Iofina:

www.iofina.com

 

Iofina plc (AIM: IOF) is a vertically integrated Company that specialises in the production of Iodine and the manufacturing of specialty chemical products. Iofina is the second largest producer of iodine in North America and operates the manufacturing entities Iofina Resources and Iofina Chemical.

 

LEI: 213800QDMFYVRJYYTQ84

ISIN: GB00B2QL5C79

 

 

Iofina Resources

Iofina Resources develops, builds, owns and operates iodine extraction plants using Iofina's WET® IOsorb® technology. Iofina currently operates five producing IOsorb® plants in Oklahoma and is consistently using technology and innovation to improve and expand its operations.

 

Iofina Chemical

Iofina Chemical has manufactured high quality halogen specialty chemicals derived from raw iodine, as well as non-iodine based products for over 38 years.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRBIBDGIGDDGDR
Date   Source Headline
29th Aug 20194:35 pmRNSPrice Monitoring Extension
13th Aug 20197:00 amRNSIncorporation of IofinaEX Global
29th Jul 20197:00 amRNSGrant of Share Options
24th Jul 20193:08 pmRNSHolding(s) in Company
16th Jul 20192:17 pmRNSHolding(s) in Company
12th Jul 20197:00 amRNSH1 2019 Update
17th Jun 20191:49 pmRNSHolding(s) in Company
17th Jun 201910:55 amRNSHolding(s) in Company
17th Jun 201910:53 amRNSHolding(s) in Company
13th Jun 201912:00 pmRNSResult of AGM and Open Offer
13th Jun 20197:00 amRNSIofinaEX Application Conditionally Approved
20th May 20197:00 amRNSProposed Placing and Open Offer
14th May 20197:00 amRNSStatement regarding share price rise
1st May 20197:00 amRNSFinal Results
17th Apr 20197:00 amRNSQ1 2019 Market Update
1st Apr 20197:00 amRNSCompletion of Debt Restructuring
22nd Feb 20194:40 pmRNSSecond Price Monitoring Extn
22nd Feb 20194:35 pmRNSPrice Monitoring Extension
12th Feb 20197:00 amRNSDebt Restructuring
1st Feb 20194:40 pmRNSSecond Price Monitoring Extn
1st Feb 20194:35 pmRNSPrice Monitoring Extension
22nd Jan 20197:00 amRNSChange of Registered Office
17th Jan 20197:00 amRNSMarket Update
20th Nov 20184:40 pmRNSSecond Price Monitoring Extn
20th Nov 20184:35 pmRNSPrice Monitoring Extension
16th Nov 20187:00 amRNSDirector Appointment
18th Oct 20184:40 pmRNSSecond Price Monitoring Extn
18th Oct 20184:35 pmRNSPrice Monitoring Extension
10th Oct 20187:00 amRNSQ3 2018 Update
20th Sep 20187:00 amRNSInterim Results
16th Jul 20187:00 amRNSH1 2018 Update
18th Jun 20187:00 amRNSMarket update
14th Jun 20187:00 amRNSGrant of Options
13th Jun 201811:30 amRNSResult of AGM
30th Apr 20187:00 amRNSFinal Results and Notice of AGM
18th Apr 20187:00 amRNSQ1 2018 Market Update
16th Apr 20181:30 pmRNSHolding(s) in Company
11th Apr 20186:20 pmRNSHolding(s) in Company
11th Apr 20186:20 pmRNSHolding(s) in Company
20th Mar 20183:05 pmRNSHolding(s) in Company
15th Mar 20181:24 pmRNSHolding(s) in Company
14th Feb 20187:00 amRNSProduction commences at IO#7
30th Jan 20183:00 pmRNSHolding(s) in Company
15th Jan 20187:00 amRNSMarket Update
14th Dec 20177:00 amRNSMarket Update
16th Nov 20177:00 amRNSIO#7 Progress and Market Update
20th Oct 20174:40 pmRNSSecond Price Monitoring Extn
20th Oct 20174:35 pmRNSPrice Monitoring Extension
10th Oct 20177:00 amRNSQ3 2017 Market Update
22nd Sep 20177:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.